Summary of Hong Kong Stock Ratings: Kaiyuan Securities Maintains a Buy Rating for Baidu Group

Cailian Press will regularly compile ratings and target prices from various institutions for Hong Kong stocks.

cls.cn15:23

Express News | Some biotechnology stocks extended their gains, with newcomer Wangshan Wangshui leading the rally by surging over 25%. Sirnaomics jumped more than 17%, CStone Pharmaceuticals rose nearly 17%, and Jemincare Pharmaceuticals gained over 8%.

Breakings11:35

Hong Kong Stock Movement | Genscript Biotech (01548) Dropped Over 4% as Affiliate Legend Biotech’s Q3 Net Loss Narrowed to US$39.7 Million

GenScript Biotech (01548) fell more than 4% against the market trend. As of the time of writing, it dropped 4.25%, trading at HKD 16.43, with a turnover of HKD 221 million.

Zhitong FinanceNov 13 13:58

Genscript Biotech (1548.HK): Legend Biotech Narrows Losses, Group’s Strategic Roadmap Clarified

Legend Biotech (48% ownership), a consolidated affiliate of the company, released its Q3 2025 earnings report: CARVYKTI achieved sales of USD 1.332 billion (+112% yoy) in the first three quarters, with Q3 sales reaching USD 5...

Huatai SecuritiesNov 13 00:00

Genscript Biotech Announces Q3 2025 Results for Legend Biotech

TipRanksNov 12 20:42

Zhitong HK Stocks Analysis | Rumors Trigger Photovoltaic Sector Decline, Market Aggressively Buys Oversold Newly Listed Consumer Stocks

Today, the photovoltaic sector was hit by rumors. Market sources indicated that the Secretary of the Board of JA Solar Technology mentioned during a monthly routine meeting of the photovoltaic industry that the 'reserve procurement platform' had failed. This was further interpreted as the failure of efforts to 'counter internal competition.'

Zhitong FinanceNov 12 19:59